13
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Virus receptors in the human central nervous system

Pages 187-195 | Published online: 10 Jul 2009

References

  • Albright AV, Strizki J, Harouse JM, Lavi E, O'Connor M, Gonzalez-Scarano F (1996). HIV-1 infection of cultured human adult oligodendrocytes. Virology 217(1): 211–219.
  • Alkhatib F, Combadiere C, Broder C, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996). CC CKR5: a RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofac-tor for macrophage-tropic HIV-1. Science 272: 1955–1958.
  • An SF, Groves M, Giometto B, Beckett AAJ, Scaravelli F (1999a). Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/insitu hybridization technique. Acta Neuropathol 98: 481–487.
  • An SF, Groves M, Gray F, Scaravilli F (1999b). Early en-try and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol 58(11): 1156–1162.
  • Atwood WJ, Berger JR, Kaderman R, Tornatore CS, Major EO (1993). Human immunodeficiency virus type 1 in-fection of the brain. Clin Microbiol Rev 6: 339–366.
  • Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Pomerantz RJ (1996). Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identifi-cation by the combination of in situ PCR and immuno-histochemistry. AIDS 10: 573–585.
  • Bearzotti M, Delmas B, Lamoureux A, Loustau AM, Chilmonczyk S, Bremont M (1999). Fish rhabdovirus cell entry is mediated by fibronectin. I Virol 73(9: 7703–7709.
  • Blake FG, Trask JD (1921). Studies on measles virus: I. Sus-ceptibility of monkeys to the measles virus. J Exp Med 33: 385–412.
  • Blixenkrone-Moller M, Bernard A, Bencsik A, Sixt N, Diamond LE, Logan JS, Wild TF (1998). Role of CD46 in measles virus infection in CD46 transgenic mice. Virology 249(2): 238–248.
  • Brack-Werner R (1999). Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 13: 1–22.
  • Brannagan TH, Nuovo GJ, Hays AP, Latov N (1997). Hu-man immunodeficiency virus infection of dorsal root ganglion neurons detecte d by polymerase chain reaction in situ hybridization. Ann Neurol 42(3): 368–372.
  • Brew BJ, Dunbar N, Pemberton L, Kaldor J (1996). Pre-dictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. I Infect Dis 174: 294–298.
  • Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB (1997). Changing incidence of AIDS-defining ill-nesses in the era of antiretroviral combination therapy. AIDS 11(14): 1731–1738.
  • Buchholz CJ, Gerlier D, Hu A, Cathomen T, Liszewski MK, Atkinson JP, Cattaneo R (1996). Selective expres-sion of a subset of measles virus receptor-competent CD46 isoforms in human brain. Virology 217(1): 349–355.
  • Chan DC, Kim PS (1998). HIV entry and its inhibition. Cell 93: 681–684.
  • Cocchi F, Menotti L, Mirandola P, Lopez M, Campadelli-Fiume G (1998). The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells. I Virol 72(12): 9992–10002.
  • Conant K, Tornatore CS, Atwood WJ, Meyers K, Traub R, Major EO (1994). In vivo and in vitro infection of the astrocyte by HIV-1. Adv Neuroimmunol 4: 1–3.
  • Davis L, Hjelle B, Miller V, Palmer D, Llewellyn A, Merlin T, Young S, Mills R, Wachsman W, Wiley C (1992). Early viral brain invasion in iatrogenic human immunodefi-ciency virus. Neurology 42: 1736–1739.
  • Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH (1993). Mechanisms of nitric oxide-mediated neurotox-icity in primary brain cultures. I Neurosci 13(6): 2651–2661.
  • Deng H, Liu R, Ellmeier W, Choe S, Unatmaz D, Burkhart M, DiMarzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661–666.
  • Doranz BJ, Rucker J, Yi Y, Smith RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW (1996). A dual tropic primary HIV-1 isolate that used fusin and the beta-chemokine receptors CCR5, CCR3 and CKR-2b as fusion cofactors. Cell 85: 1149–1158.
  • Dore, GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ (1999). Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13(10): 1249–1253.
  • Dorig RE, Marcil A, Chopra A, Richardson CD (1993). The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75(2): 295–305.
  • Epstein L, Gendelman H (1993). Human immunodeficiency virus type 1 infection of the nervous system: patho-genetic mechanisms. Ann Neurol 33: 429–436.
  • Everall I, Luthert P, Lantos P (1991). Neuronal loss in the frontal cortex in HIV infection. Lancet 337: 1119–1121.
  • Freistadt MS, Stoltz DA, Eberle KE (1995). Role of po-liovirus receptors in the spread of the infection. Ann NY Acad Sci 753: 37–47.
  • Gabuzda D, Ho D, De La Monte S, Hirsch M, Rota T, Sobel R (1986). Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 20: 289–295.
  • Gastka M, Horvath J, Lentz TL (1996). Rabies virus bind-ing to the nicotinic acetylcholine receptor alpha subunit demonstrated by virus overlay protein binding assay. J Gen Virol 77\(Pt 10): 2437–2440.
  • Gelbard HA, James HJ, Sharer LR, Perry SW, Kazee AM, Saito Y, Blumberg BM, Epstein LG (1995). Apop-totic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol 21: 208–217.
  • Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG (1998). Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280(5369): 1618–1620.
  • Griffin DE, Bellini WJ (1996). Measles virus. In: Fields Virology. Fields B (ed). Lippincott-Raven, Philadelphia, pp 1267-1312.
  • Gromeier M, Lu HH, Bernhardt G, Harber JJ, Bibb JA, Wimmer E (1995). The human poliovirus receptor. Receptor-virus interaction and parameters of disease specificity. Ann 1VY Acad Sci 753: 19–36.
  • Hao H, Lyman WD (1999). HIV infection of fetal human astrocytes: the potential role of a receptor-mediated en-docytic pathway. Brain Res 823: 24–32.
  • He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay CR, Sodroski J, Gabuzda D (1997). CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645–649.
  • HesselgesserJ, Horuk R (1999). Chemokine and chemokine receptor expression in the central nervous system. J Neu-rovirol 5, 13–26.
  • Horvat B, Rivailler P, Varior-Krishnan G, Cardoso A, Gerlier D, Rabourdin-Combe C (1996). Transgenic mice express-ing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infection. I Virol 70: 6673–6681.
  • Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S, Roberts JR, Gitt J, Saini N, Lux W (1988). Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocalleukoencephalopathy. NEngl J. Med 318: 301–305.
  • Johnson RT (1998). Viral infections of the nervous system. 2nd ed. Lippincott-Raven, Philadelphia.
  • Jordan CA, Watkins BA, Kufta C, Dubois-Dalcq M (1991). Infection of brain microglial cells by human immunod-eficiency virus type 1. J. Virol 65: 736–742.
  • Kerza-Kwiatecki AP, Amini S (1999). CNS as an HIV-1 reservoir; BBB and drug delivery. I Neurovirol 5: 113–114.
  • Koenig S, Gendelman H, Orenstein J, Dal Canto M, Pezeshkpour G, Yungbluth M, Janotta F, Aksamit A, Martin M, Fauci A (1986). Detection of AIDS virus in macrophages in brain tissue from AIDS patients. Sci-ence 233: 1089–1093.
  • Kolson DL, Lavi E, Gonzalez-Scarano F (1998). The effects of human immunodeficiency virus in the central ner-vous system. Adv Virus Res 50: 1–700.
  • Krah DL, Choppin PW (1988). Mice immunized with measles virus develop antibodies to a cell surface re-ceptor for binding virus. I Virol 62(5): 1565–1572.
  • Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA (1998). Structure of an HIV gp120 en-velope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393: 648–659.
  • Lawrence DM, Patterson CE, Gales TL, D'Orazio JL, Vaughn MM, Rall GF (2000). Measles virus spread between neu-rons requires cell contact but not CD46 expression, syn-cytium formation, or extracellular virus production. I Virol 74(4): 1908–1918.
  • Lentz TL, Burrage TG, Smith AL, Crick J, Tignor GH (1982). Is the acetylcholine receptor a rabies virus receptor? Sci-ence 215: 182–184.
  • Leon-Monzon ME, Illa I, Dalakas MC (1995). Expression of poliovirus receptor in human spinal cord and muscle. Ann NY Acad Sci 753: 48–57.
  • Lipton SA (1994). HIV-related neuronal injury. Mol Neuro-biol 8: 181–196.
  • Liszewski MK, Post TW, Atkinson JP (1991). Membrane co-factor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 9: 431–455.
  • Littman DR (1998). Chemokine receptors: keys to AIDS pathogenesis. Cell 93: 677–680.
  • Liu CK, Wei G, Atwood WJ (1998). Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha 2–6 linked sialic acids. I Virol 72: 4643–4649.
  • Ma M, Geiger JD, Nath A (1994). Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal as-trocytes. I Virol 68(10): 6824–6828.
  • Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR (1992). Pathogenesis and molecular biology of pro-gressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5: 49–73.
  • Manchester M, Liszewski MK, Atkinson JP, Oldstone MB (1994). Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc Natl Acad Sci USA 91(6): 2161–2165.
  • Manchester M, Naniche D, Stehle T (2000). CD46 as a measles receptor: form follows function. Virology 274(1): 5–10.
  • Masliah E, Ge N, Morey M, DeTeresa R, Terry, R, Wiley C (1992). Spectrum of human immunodeficiency virus associated neocortical damage. Ann Neurol 32: 321–329.
  • McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER (1997). Relationship between human immunodeficiency virus-associated de-mentia and viral load in cerebrospinal fluid and brain. Ann Neurol 42: 689–698.
  • McChesney MB, Oldstone MB (1989). Virus-induced im-munosuppression: infections with measles virus and human immunodeficiency virus. Adv Immunol 45: 335–380.
  • Mendelsohn CL, Wimmer E, Racaniello VR (1989). Cellular receptor for poliovirus:molecular cloning, nucleotide sequence, and expression of a new member of the im-munoglobulin superfamily. Cell 56: 855–865.
  • Monaco MGC, Atwood WJ, Gravell M, Tornatore CS, Major EO (1996). JCV infection of hematopoetic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: Implication for viral latency. I Virol 70: 7004–7012.
  • Montgomery RI, Warner MS, Lum BJ, Spear PG (1996). Herpes simplex virus-1 entry into cells is mediated by a novel member of the TNF/NGF receptor family. Cell 87: 427–436.
  • Mrkic B, Pavlovic J, Rulicke T, Volpe P, Buchholz CJ, Hourcade D, Atkinson JP, Aguzzi A, Cattaneo R (1998). Measles virus spread and pathogenesis in genetically modified mice. I Virol 72(9): 7420–7427.
  • Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D (1993a). Human mem-brane cofactor protein (CD46) acts as a cellular receptor for measles virus. I Virol 67(10): 6025–6032.
  • Naniche D, Wild TF, Rabourdin-Combe C, Gerlier D (1993b). Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding. I Gen Virol 74\(Pt 6): 1073–1079.
  • Nath A, Hartloper V, Furer M, Fowke KR (1995). Infection of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. I Neuropathol Exp Neurol 54: 320–330.
  • Nuovo GJ, Alfieri ML (1996). AIDS dementia is associated with massive, activated HIV-1 infection and concomi-tant expression of several cytokines. Mol Med 2(3): 358–366.
  • Nuovo, GJ, Gallery F, MacConnell P, Braun A (1994). In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am J Pathol 144: 659–666.
  • Ogata A, Czub S, Ogata S, Cosby SL, McQuaid S, Budka H, ter Meulen V, Schneider-Schaulies J (1997). Absence of measles virus receptor (CD46) in lesions of subacute sclerosing panencephalitis brains. Acta Neuropathol (Berl) 94(5): 444–449.
  • Oldstone MB, Lewicki H, Thomas D, Tishon A, Dales S, Patterson J, Manchester M, Homann D, Naniche D, Holz A (1999). Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell 98(5): 629–640.
  • Padgett B, ZuRhein G, Walker D, Echroade R, Dessel B (1971). Cultivation of papova-like virus from human brain with progressive multifoc al leukoencephalopathy. Lancet I: 1257–1260.
  • Plotkin SA (2000). Rabies. Clin Infect Dis 30(1): 4–12.
  • Rall GF, Manchester M, Daniels LR, Callahan EM, Belman AR, Oldstone MB (1997). A transgenic mouse model for measles virus infection of the brain. Proc Natl Acad Sci USA 94(9): 4659–4663.
  • Ranki A, Nyberg M, Ovod V (1995). Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9: 1001–1008.
  • Rizzuto CD, Wyatt R, Hernandez-Ramos N, Sun Y, Kwong PD, Hendrickson WA, Sodroski J (1998). A con-served HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280: 1949–1953.
  • Roizman B, Sears AE (1996). Herpes Simplex Viruses and their replication. In: Fundamental Virology. Fields BN, Knipe DM, Howley PM (eds). Lippincott-Raven, Philadelphia, pp 1043-1107.
  • Rueckert RR (1996). Picornaviridae: The viruses and their replication. In: Fundamental Virology Fields BN, Knipe DM, Howley PM (eds). Lippincott-Raven, Philadelphia, pp 477-522.
  • Sabri F, Tresoldi E, Di Stefano M, Polo S, Monaco MC, Verani A, Fiore JR, Lusso P, Major E, Chiodi F, Scarlatti G (1999). Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Virology 264: 370–384.
  • Schweighardt B, Atwood WJ (2000). Glial cells as targets of viral infection in the human central nervous system. In: Glial Cell Function Nieto-Sampedro M, Castellano B, (eds). Vol. 132. Elsevier Press, Amsterdam, pp 731-745.
  • Schweighardt B, Shieh, JTC, Atwood WJ (2001). CD4/ CXCR4 independent infection of human astrocytes by a T-tropic strain of HIV-1. J Neuro Virol in press.
  • Shieh JTC, Albright AV, Sharron M, Gartner S, Strizki J, Doms RW, Gonzalez-Scarano F (1998). Chemokine re-ceptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. I Virol 72: 4243–4249.
  • Soontornniyomkij V, Nieto-Rodriguez JA, Martinez AJ, Kingsley L A, Achim CL, and Wiley CA (1998). Brain HIV burden and length of survival after AIDS diagnosis. Clin Neuropathol 17: 95–99.
  • Spear PG, Eisenberg RJ, Cohen GH (2000). Three classes of cell surface receptors for alphaherpesvirus entry. Virol-ogy 275(1): 1–8.
  • Thoulouze MI, Lafage M, Schachner M, Hartmann U, Cremer H, Lafon M (1998). The neural cell adhesion molecule is a receptor for rabies virus. I Virol 72(9), 7181–7190.
  • Tomassini JE, Colonno RJ (1986). Isolation of a receptor protein involved in attachment of human rhinoviruses. Virol 58(2): 290–295.
  • Tornatore C, Chandra R, Berger JR, Major EO (1994a). HIV-1 infection of subcortical astrocytes in the pediatric cen-tral nervous. Neurology 44: 481–487.
  • Tornatore C, Meyers K, Atwood W, Conant K, Major E (1994b). Temporal patterns of human immunodefi-ciency virus type 1 transcripts in human fetal astrocytes. Virol 68: 93–102.
  • Tornatore C, Nath A, Amemiya K, Major EO (1993). Per-sistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. I Virol 65: 6094–6100.
  • Tornatore CS, Nath A, Amemiya K, Major EO (1991). Persis-tent human immunodeficiency virus type 1 infection in human glial cells reactivated by T cell factors or by the cytokines tumor necrosis factor alpha and interleukin 1 beta. I Virol 65: 6094–6100.
  • Tuffereau C, Benejean J, Blondel D, Kieffer B, Flamand A (1998). Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. Embo J17(24): 7250–7259.
  • Warner MS, Geraghty RJ, Martinez WM, Montgomery RI, Whitbeck JC, Xu R, Eisenberg RJ, Cohen GH, Spear, PG (1998). A cell surface protein with herpesvirus entry ac-tivity (HveB) confers susceptibility to infection by mu-tants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246(1): 179–189.
  • Watkins BA, Dorn HH, Kelly WB, Armstrong RC, Potts BJ, Michaels F, Kufta CV, Dubois-Dalcq M (1990). Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 249: 549–552.
  • Wei G, Liu CK, Atwood WJ (2000). JC Virus binds to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T-lymphcytes. I Neurovirol 6(2): 127–136.
  • Wild TF, Malvoisin E, Buckland R (1991). Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. I Gen Virol 72\(Pt 2): 439–442.
  • Wiley C, Schrier R, Nelson J, Lampert P, Oldstone M (1986). Cellular localization of human immunodeficiency virus infection within the brains of aquired immune defi-ciency patients. Proc Nail Acad Sci USA 83: 7089–7093.
  • WuDunn D, Spear PG (1989). Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. I Virol 63(1): 52–58.
  • Wyatt R, Kwong PD, Desjardins E, Sweet R, Robinson J, Hendrickson WA, Sodroski J (1998). The antigenic structure of HIV gp120 envelope protein. Nature 393: 705–711.
  • Zhou L, Lin X, Green TJ, Lipton HL, Luo M (1997). Role of sialyloligosaccharide binding in Theiler's virus persistence. I Virol 71(12): 9701–9712.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.